Literature DB >> 2408336

Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.

D R Milich, G B Thornton, A R Neurath, S B Kent, M L Michel, P Tiollais, F V Chisari.   

Abstract

The 55 codons upstream of the gene sequence encoding the hepatitis B surface antigen (HBsAg) are called the pre-S(2) region. It has been proposed that polypeptides of high molecular weight that contain the pre-S(2) region should be included in future hepatitis B virus (HBV) vaccines. The pre-S(2) region and the S gene product [25 kilodalton (kD)] together compose a polypeptide of high molecular weight (33 kD). As an initial attempt to determine the relevance of the 33-kD polypeptide to development of an HBV vaccine, the murine immune response to pre-S(2)-encoded determinants as compared to S-encoded determinants on the same polypeptide was examined. The results indicate (i) the pre-S(2) region is significantly more immunogenic than the S region of HBsAg, (ii) the 26 amino acid residues at the NH2-terminus of the 33-kD polypeptide represent a dominant antibody binding site on the pre-S(2) region, (iii) the immune response to the pre-S(2) region is regulated by H-2-linked genes distinct from those that regulate the response to the S region, and (iv) immunization of an S region nonresponder strain with HBV envelope particles that contain both the pre-S(2) and S regions can circumvent nonresponsiveness to the S region.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408336     DOI: 10.1126/science.2408336

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  61 in total

1.  Duck hepatitis B virus can tolerate insertion, deletion, and partial frameshift mutation in the distal pre-S region.

Authors:  J S Li; L Cova; R Buckland; V Lambert; G Deléage; C Trépo
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

Review 2.  Strategies for hepatitis B immunisation.

Authors:  A P Catterall; I M Murray-Lyon
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

3.  Immunological response to two hepatitis B vaccines administered in two different schedules.

Authors:  K M Girisha; J R Kamat; G Nataraj
Journal:  Indian J Pediatr       Date:  2006-06       Impact factor: 1.967

Review 4.  Virus-like particles production in green plants.

Authors:  Luca Santi; Zhong Huang; Hugh Mason
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

5.  Cell-mediated immunity to hepatitis B virus antigens in mice: correlation of in vivo and in vitro assays.

Authors:  P A De Moerloose; I H Frazer; W A Sewell; E J Collins; I R Mackay
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

6.  The cellular basis for lack of antibody response to hepatitis B vaccine in humans.

Authors:  E Egea; A Iglesias; M Salazar; C Morimoto; M S Kruskall; Z Awdeh; S F Schlossman; C A Alper; E J Yunis
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

7.  The N-terminal (pre-S2) domain of a hepatitis B virus surface glycoprotein is translocated across membranes by downstream signal sequences.

Authors:  B E Eble; V R Lingappa; D Ganem
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

8.  Immunohistochemical study of pre-S(2) antigen in liver and serum of patients with chronic hepatitis B.

Authors:  K Takaguchi; G Yamada; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1990-06

9.  High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity.

Authors:  Tran Thien-Tuan Huy; Hiroshi Ushijima; Khin Maung Win; Pairoj Luengrojanakul; Pradeep Krishna Shrestha; Zhao-Hua Zhong; Andrei V Smirnov; Teresa Casanovas Taltavull; Tetsutaro Sata; Kenji Abe
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

10.  Virological pattern of hepatitis B infection in an HIV-positive man with fatal fulminant hepatitis B: a case report.

Authors:  Sabrina Bagaglio; Luca Albarello; Priscilla Biswas; Caterina Uberti-Foppa; Claudio Fortis; Giulia Morsica
Journal:  J Med Case Rep       Date:  2009-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.